Release Date: 30/10/18 11:28 Summary: Quarterly Activities and Cashflow report to 30 Sept 2018 Price Sensitive: Yes Download Document 899.81KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status